- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 13, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in this month’s issue of The American Journal of Managed Care® (AJMC®) evaluated the patterns of clinical service for long-term nursing home residents enrolled in UnitedHealthcare’s Medicare Advantage Institutional Special Needs Plans. The study, “Managed Care for Long-Stay Nursing Home Residents: An Evaluation of Institutional Special Needs Plans,” was featured in an article in Skilled Nursing News.
The study “The Potential Impact of CAR T-Cell Treatment Delays on Society,” which was published in the August issue of AJMC®, was the focus of an article from Hematology Advisor. The study concluded that the social value of chimeric antigen receptor (CAR) T-cell therapy is significantly limited by treatment delays and that efficient payment mechanisms, adequate capital, and payment policy reform are urgently needed to increase patient access and maximize the value of the treatment.
Mountain Grove News Journal’s article on the impact of depression referred to a 2014 study published in AJMC®, which examined health claims data to assess medication adherence rates and healthcare costs for psychiatric patients. The study, “Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings,” found that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.
AJMC®’s video series “Identifying Secondary Progressive Multiple Sclerosis” was highlighted by Multiple Sclerosis News Today. The video series, which features multiple key opinion leaders, includes discussions on the nature and cost of multiple sclerosis, debates on whether it is truly an autoimmune disease, and more.
Both EcoWatch and Xherald included an article from AJMC.com, the website of AJMC®, in their pieces on the impact of sugary drinks. The article, “Large European Study Links Soda Consumption to Greater Risk of Mortality, Including From Parkinson,” reported on study findings showing that soft drinks were linked to a greater risk of death, as well as a higher chance of dying from Parkinson disease.
The National Pharmaceutical Council included AJMC®’s interview with Ajai Chari, MD, associate professor of medicine, Hematology and Medical Oncology, Mount Sinai Hospital, in its Wednesday newsfeed. During the interview, Chari discussed the importance of real-world evidence in multiple myeloma.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
A Focus on MAHA, Lasting Changes to Health Care Programs for Trump’s Second Term
March 13th 2025The second Trump administration is expected to bring changes to Medicaid, Medicare Advantage, and the health insurance exchanges, as well as highlight the Make America Healthy Again (MAHA) movement, speakers at the Value-Based Insurance Design Summit said.
Read More
